Cessation

Research

A content analysis of popular smartphone apps for smoking cessationAmerican Journal of Preventive Medicine. A study examining the most popular 47 iPhone and 51 Android smoking cessation smartphone applications (apps) found that apps generally had a low level of adherence to the U.S. Public Health Service’s Clinical Practice Guidelines for Treating Tobacco Use and Dependence, averaging 12.9 out of 42, indicating a lack of evidence-based practices such as encouraging quitline use. To learn more, click here, or click here for the study abstract.

Cardiovascular events associated with smoking cessation pharmacotherapies: A network meta-analysisCirculation. An analysis of 63 randomized control trials involving nicotine replacement therapies (NRTs), bupropion, and/or varenicline found no increase in the risk of all-cardiovascular disease (CVD) events with bupropion or varenicline. There was an elevated risk associated with NRTs that was predominantly driven by less serious events. Researchers concluded that smoking cessation therapies do not appear to raise the risk of serious CVD events.

top


Reports

"Beyond the 5 A's" smoking cessation training resourcesNorth American Quitline Consortium. Following the November 2013 conference, continuing education is available on the conference website to improve the frequency and effectiveness of smoking cessation interventions provided by health professionals.

top

Back to Table of Contents

 

 

contact_email